3 "Kathy Miller, Md" clinical studies found.

• DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

  This clinical trial studies nivolumab and ipilimumab in treating patients with rare tumors.

  Kathy Miller, Md

• A Randomized Phase II Study of Pembrolizumab an anti-PD (programmed cell death)-1 Antibody in Combination with Carboplatin Compared to ...

  This study is being done to see what effects the combination of pembrolizumab and carboplatin have on breast cancer compared ...

  Kathy Miller, Md

• A Phase I Study of ASTX727 plus Talazoparib in Patients with Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer

  The purpose of this study is to test the safety of a combination of two drugs, ASTX727 (cedazuridine and decitabine ...

  Kathy Miller, Md